204 related articles for article (PubMed ID: 30016325)
1. Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.
Schaake W; van der Schaaf A; van Dijk LV; van den Bergh ACM; Langendijk JA
PLoS One; 2018; 13(7):e0197757. PubMed ID: 30016325
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.
Schaake W; van der Schaaf A; van Dijk LV; Bongaerts AH; van den Bergh AC; Langendijk JA
Radiother Oncol; 2016 Jun; 119(3):381-7. PubMed ID: 27157889
[TBL] [Abstract][Full Text] [Related]
3. External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.
Devisetty K; Zorn KC; Katz MH; Jani AB; Liauw SL
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1060-5. PubMed ID: 20045267
[TBL] [Abstract][Full Text] [Related]
4. Voxel-Based Analysis for Identification of Urethrovesical Subregions Predicting Urinary Toxicity After Prostate Cancer Radiation Therapy.
Mylona E; Acosta O; Lizee T; Lafond C; Crehange G; Magné N; Chiavassa S; Supiot S; Ospina Arango JD; Campillo-Gimenez B; Castelli J; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):343-354. PubMed ID: 30716523
[TBL] [Abstract][Full Text] [Related]
5. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
Harsolia A; Vargas C; Yan D; Brabbins D; Lockman D; Liang J; Gustafson G; Vicini F; Martinez A; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1100-9. PubMed ID: 17967304
[TBL] [Abstract][Full Text] [Related]
6. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
Kollmeier MA; Stock RG; Cesaretti J; Stone NN
J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
[TBL] [Abstract][Full Text] [Related]
7. Urinary incontinence in prostate cancer patients treated with external beam radiotherapy.
Liu M; Pickles T; Berthelet E; Agranovich A; Kwan W; Tyldesley S; McKenzie M; Keyes M; Morris J; Pai H;
Radiother Oncol; 2005 Feb; 74(2):197-201. PubMed ID: 15818868
[TBL] [Abstract][Full Text] [Related]
8. Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder Surface.
Yahya N; Ebert MA; House MJ; Kennedy A; Matthews J; Joseph DJ; Denham JW
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):420-426. PubMed ID: 28068247
[TBL] [Abstract][Full Text] [Related]
9. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
[TBL] [Abstract][Full Text] [Related]
10. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
11. Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer.
Anttinen M; Mäkelä P; Nurminen P; Yli-Pietilä E; Suomi V; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
Scand J Urol; 2020 Dec; 54(6):481-486. PubMed ID: 32897169
[TBL] [Abstract][Full Text] [Related]
12. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
Küpeli S; Yilmaz E; Soygür T; Budak M
J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
[TBL] [Abstract][Full Text] [Related]
14. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B; Studer UE; Fowler CJ; Kessler TM
J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
[TBL] [Abstract][Full Text] [Related]
15. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.
Ishiyama H; Hirayama T; Jhaveri P; Satoh T; Paulino AC; Xu B; Butler EB; Teh BS
Am J Clin Oncol; 2014 Jun; 37(3):297-304. PubMed ID: 22706173
[TBL] [Abstract][Full Text] [Related]
16. Preoperative symptoms predict continence after post-radiation transurethral resection of prostate.
Polland A; Vertosick EA; Sjoberg DD; Stearns GL; Leddy LS; Kollmeier MA; Sandhu JS
Can J Urol; 2017 Aug; 24(4):8903-8909. PubMed ID: 28832309
[TBL] [Abstract][Full Text] [Related]
17. Prevalence analysis of urinary incontinence after radical prostatectomy and influential preoperative factors in a single institution.
Tienza A; Robles JE; Hevia M; Algarra R; Diez-Caballero F; Pascual JI
Aging Male; 2018 Mar; 21(1):24-30. PubMed ID: 28857655
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.
Kittel JA; Reddy CA; Smith KL; Stephans KL; Tendulkar RD; Ulchaker J; Angermeier K; Campbell S; Stephenson A; Klein EA; Wilkinson DA; Ciezki JP
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):884-93. PubMed ID: 25962627
[TBL] [Abstract][Full Text] [Related]
19. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
